These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A, Eo W, Lee S. World J Gastroenterol; 2015 Nov 21; 21(43):12410-20. PubMed ID: 26604648 [Abstract] [Full Text] [Related]
9. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Medicine (Baltimore); 2016 May 21; 95(18):e3582. PubMed ID: 27149487 [Abstract] [Full Text] [Related]
10. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma. Abe T, Nakata K, Kibe S, Mori Y, Miyasaka Y, Ohuchida K, Ohtsuka T, Oda Y, Nakamura M. Ann Surg Oncol; 2018 Dec 21; 25(13):3996-4003. PubMed ID: 30225838 [Abstract] [Full Text] [Related]
11. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas. Kiuchi K, Hasegawa K, Ochiai S, Motegi E, Kuno T, Kosaka N, Fukasawa I. J Obstet Gynaecol; 2019 Feb 21; 39(2):237-241. PubMed ID: 30370797 [Abstract] [Full Text] [Related]
12. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Am J Surg; 2010 Aug 21; 200(2):197-203. PubMed ID: 20122680 [Abstract] [Full Text] [Related]
14. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, Ajiki T, Fukumoto T, Ku Y. Surg Today; 2016 May 21; 46(5):583-92. PubMed ID: 26108488 [Abstract] [Full Text] [Related]
18. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA. Intern Med J; 2014 Jul 21; 44(7):676-82. PubMed ID: 24750233 [Abstract] [Full Text] [Related]
19. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients. Zheng L, Zou K, Yang C, Chen F, Guo T, Xiong B. Clin Transl Oncol; 2017 Sep 21; 19(9):1125-1132. PubMed ID: 28315180 [Abstract] [Full Text] [Related]
20. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL, Li SQ, Peng BG, Liang LJ, Hua YP. BMC Cancer; 2016 Feb 22; 16():137. PubMed ID: 26907597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]